{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:12:52Z","timestamp":1788469972139,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jmoldx.2019.12.009","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T03:27:45Z","timestamp":1581046065000},"page":"457-466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Differential Diagnosis of Malignant Pleural Mesothelioma on Cytology"],"prefix":"10.1016","volume":"22","author":[{"given":"Rossella","family":"Bruno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Al\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0212-8249","authenticated-orcid":false,"given":"Anello M.","family":"Poma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0180-6554","authenticated-orcid":false,"given":"Agnese","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Libener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narciso","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Niccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Chella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Ribechini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Grosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Fontanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2019.12.009_bib1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib2","first-page":"260","article-title":"Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province","volume":"17","author":"Wagner","year":"1960","journal-title":"Br J Ind Med"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","article-title":"The 2015 World Health Organization classification of tumors of the pleura: advances since the 2004 classification","volume":"11","author":"Galateau-Salle","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib4","first-page":"491","article-title":"Malignant pleural mesothelioma: an epidemiological perspective","volume":"1","author":"Robinson","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib5","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/ijc.26229","article-title":"Pleural malignant mesothelioma epidemic: incidence, modalities of asbestos exposure and occupations involved from the Italian National Register","volume":"130","author":"Marinaccio","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib6","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.21037\/jtd.2017.10.125","article-title":"The pathological and molecular diagnosis of malignant pleural mesothelioma: a literature review","volume":"10","author":"Al\u00ec","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.5858\/arpa.2018-0020-RA","article-title":"Cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: ten years of clinical experience in relation to international guidelines","volume":"142","author":"Hjerpe","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the International Mesothelioma Interest Group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/1742-6413.170726","volume":"12","author":"Hjerpe","year":"2015","journal-title":"Cytojournal"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/dc.23491","article-title":"BAP1 immunostain and CDKN2A (p16) FISH analysis: clinical applicability for the diagnosis of malignant mesothelioma in effusions","volume":"44","author":"Walts","year":"2016","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib11","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/cas.12769","article-title":"Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue","volume":"106","author":"Hida","year":"2015","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib12","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cigognetti","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/dc.23490","article-title":"Cytologic differential diagnosis of malignant mesothelioma and reactive mesothelial cells with FISH analysis of p16","volume":"44","author":"Hiroshima","year":"2016","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/dc.23837","article-title":"Loss of BRCA1-associated protein 1 (BAP1) expression is useful in diagnostic cytopathology of malignant mesothelioma in effusions","volume":"46","author":"Cozzi","year":"2018","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib15","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/PAS.0000000000000394","article-title":"BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations","volume":"39","author":"Sheffield","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PAS.0000000000000529","article-title":"Utility of BAP1 immunohistochemistry and p16 (CDKN2A) FISH in the diagnosis of malignant mesothelioma in effusion cytology specimens","volume":"40","author":"Hwang","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5858\/arpa.2015-0240-SA","article-title":"New markers for separating benign from malignant mesothelial proliferations: are we there yet?","volume":"140","author":"Churg","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.lungcan.2018.07.041","article-title":"Highlights of the 14th International Mesothelioma Interest Group meeting: pathologic separation of benign from malignant mesothelial proliferations and histologic\/molecular analysis of malignant mesothelioma subtypes","volume":"124","author":"Churg","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lungcan.2016.12.017","article-title":"Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: comparison with 9p21 FISH and BAP1 immunohistochemistry","volume":"104","author":"Hida","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/cncy.21928","article-title":"A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma","volume":"126","author":"Kinoshita","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.lungcan.2019.02.004","article-title":"Highly expressed EZH2 in combination with BAP1 and MTAP loss, as detected by immunohistochemistry, is useful for differentiating malignant pleural mesothelioma from reactive mesothelial hyperplasia","volume":"130","author":"Yoshimura","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/cyto.a.22602","article-title":"Detection of malignant mesothelioma using nuclear structure of mesothelial cells in effusion cytology specimens","volume":"87","author":"Tosun","year":"2015","journal-title":"Cytometry A"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib23","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.18632\/oncotarget.13174","article-title":"Malignant pleural mesothelioma and mesothelial hyperplasia: a new molecular tool for the differential diagnosis","volume":"8","author":"Bruno","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib24","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","article-title":"Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib25","first-page":"453","article-title":"On oblique random forests","volume":"6912","author":"Menze","year":"2011"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1183\/09059180.00007014","article-title":"Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic","volume":"24","author":"R\u00f8e","year":"2015","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib27","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.5858\/arpa.2012-0112-RA","article-title":"The separation of benign and malignant mesothelial proliferations","volume":"136","author":"Churg","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/carcin\/bgh276","article-title":"L1CAM, INP10, P-cadherin, tPA and ITGB4 over-expression in malignant pleural mesotheliomas revealed by combined use of cDNA and tissue microarray","volume":"26","author":"Kettunen","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib29","doi-asserted-by":"crossref","first-page":"e0150044","DOI":"10.1371\/journal.pone.0150044","article-title":"Analysis of gene expression in 3D spheroids highlights a survival role for ASS1 in mesothelioma","volume":"11","author":"Barbone","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib30","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.chest.2016.12.004","article-title":"Malignant mesothelioma biomarkers","volume":"152","author":"Creaney","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib32","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1158\/1535-7163.MCT-15-0583","article-title":"Antagonizing the hedgehog pathway with vismodegib impairs malignant pleural mesothelioma growth in\u00a0vivo by affecting stroma","volume":"15","author":"Meerang","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib33","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/carcin\/bgm047","article-title":"Targeting survivin in cancer therapy: fulfilled promises and open questions","volume":"28","author":"Pennati","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib34","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/annonc\/mdu127","article-title":"Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications","volume":"25","author":"Suraokar","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib35","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ejmech.2017.11.058","article-title":"Design, synthesis, and biological evaluation of novel highly selective polo-like kinase 2 inhibitors based on the tetrahydropteridin chemical scaffold","volume":"143","author":"Zhan","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib36","doi-asserted-by":"crossref","first-page":"E20028","DOI":"10.1200\/JCO.2017.35.15_suppl.e20028","article-title":"Novel prognostic markers for epithelioid malignant pleural mesothelioma","volume":"35 Suppl","author":"Bruno","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib37","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1158\/0008-5472.CAN-15-0262","article-title":"Evaluating robustness and sensitivity of the NanoString technologies nCounter platform to enable multiplexed gene expression analysis of clinical samples","volume":"75","author":"Veldman-Jones","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2019.12.009_bib38","doi-asserted-by":"crossref","first-page":"34796","DOI":"10.18632\/oncotarget.16276","article-title":"Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer","volume":"8","author":"Lindquist","year":"2017","journal-title":"Oncotarget"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157820300192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157820300192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:14:00Z","timestamp":1761502440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157820300192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1525157820300192"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2019.12.009","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential Diagnosis of Malignant Pleural Mesothelioma on Cytology","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2019.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}